Market Place
Sourcing Support
Grants From Centro Para El Desarrollo Tecnológico Y La Innovación
18 Jun 2024 //
PRESS RELEASE
Dr. Reddy`s Labs partners with Bayer for second brand of Vericiguat for India market
06 Apr 2024 //
PRESS RELEASE
Heart disease needs a new drug – Vericiguat
09 Feb 2022 //
PRESS RELEASE
Merck commences Phase III trial of Verquvo for heart failure
13 Nov 2021 //
CLINICALTRIALSARENA
Merck Begins Phase 3 Study of VERQUVO in CHF and Reduced Ejection Fraction
11 Nov 2021 //
BUSINESSWIRE
Bayer`s Verquvo (vericiguat) Receives Approval in Europe
16 Jul 2021 //
EMA
US approval for MSD’s heart failure med Verquvo
21 Jan 2021 //
PHARMATIMES
Merck, Bayer win FDA approval for heart failure drug
21 Jan 2021 //
BIOPHARMADIVE
Merck, Bayer`s new Verquvo faces tough heart failure market
20 Jan 2021 //
FIERCEPHARMA
Bayer submits vericiguat for marketing authorization in China for the treatment
28 Aug 2020 //
PHARMASHOTS
FDA puts Merck`s heart failure drug on priority review track
17 Jul 2020 //
FIERCEBIOTECH
FDA Grants Priority Review to Merck’s New Drug Application for Vericiguat
16 Jul 2020 //
BUSINESSWIRE
Bayer submits vericiguat for marketing authorization in the EU and Japan
04 Jun 2020 //
PIPELINEREVIEW
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.